Knockdown of NIK only partially alleviated resistance to venetoclax in primary CLL cells, which may be explained by the fact that the knockdown was not complete as non-canonical NF-κB signaling was still active to some degree, as observed by the presence of p52. This evidence concerns the gene MAP3K14 and B-cell chronic lymphocytic leukemia.